Citadel Advisors - CONMED CORP ownership

CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CONMED CORP
ValueSharesWeighting
Q2 2023$5,459,994
-91.6%
3,543,000
-91.2%
0.00%
-93.3%
Q2 2021$64,859,000
-29.4%
40,121,000
-31.6%
0.02%
-34.8%
Q1 2021$91,854,000
-12.0%
58,621,000
-21.3%
0.02%
-14.8%
Q4 2020$104,370,000
-16.0%
74,522,000
-32.6%
0.03%
-22.9%
Q3 2020$124,216,000
+21.4%
110,522,000
+13.3%
0.04%
-2.8%
Q2 2020$102,294,000
+14.8%
97,522,000
+3.0%
0.04%
-10.0%
Q1 2020$89,071,00094,722,0000.04%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,840,000$3,958,0004.02%
ZAZOVE ASSOCIATES LLC 13,564,000$18,956,0002.33%
SHENKMAN CAPITAL MANAGEMENT INC 10,584,000$15,014,0001.57%
SSI INVESTMENT MANAGEMENT LLC 8,349,000$11,673,0000.83%
OSTERWEIS CAPITAL MANAGEMENT INC 8,930,000$12,528,0000.75%
MACKAY SHIELDS LLC 32,384,000$45,397,0000.31%
ADVENT CAPITAL MANAGEMENT /DE/ 8,379,000$11,734,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 5,271,000$7,387,0000.19%
Calamos Advisors LLC 23,007,000$32,262,0000.19%
WESTWOOD HOLDINGS GROUP INC 10,200,000$14,415,0000.17%
View complete list of CONMED CORP shareholders